These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17233116)
1. Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin. Grosel A; Sersa G; Kranjc S; Cemazar M DNA Cell Biol; 2006 Dec; 25(12):674-83. PubMed ID: 17233116 [TBL] [Abstract][Full Text] [Related]
2. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status. Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587 [TBL] [Abstract][Full Text] [Related]
3. Cancer electrogene therapy with interleukin-12. Cemazar M; Jarm T; Sersa G Curr Gene Ther; 2010 Aug; 10(4):300-11. PubMed ID: 20560875 [TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model. Kranjc S; Tevz G; Kamensek U; Vidic S; Cemazar M; Sersa G Radiat Res; 2009 Dec; 172(6):677-85. PubMed ID: 19929414 [TBL] [Abstract][Full Text] [Related]
5. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Cemazar M; Milacic R; Miklavcic D; Dolzan V; Sersa G Anticancer Drugs; 1998 Jul; 9(6):525-30. PubMed ID: 9877240 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Sedlar A; Dolinsek T; Markelc B; Prosen L; Kranjc S; Bosnjak M; Blagus T; Cemazar M; Sersa G Radiol Oncol; 2012 Dec; 46(4):302-11. PubMed ID: 23412658 [TBL] [Abstract][Full Text] [Related]
8. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Sersa G; Kranjc S; Cemazar M Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):1037-41. PubMed ID: 10705027 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo experiments on electrochemotherapy for bladder cancer. Vásquez JL; Ibsen P; Lindberg H; Gehl J J Urol; 2015 Mar; 193(3):1009-15. PubMed ID: 25245485 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated p53 gene therapy inhibits human sarcoma tumorigenicity. Milas M; Yu D; Lang A; Ge T; Feig B; El-Naggar AK; Pollock RE Cancer Gene Ther; 2000 Mar; 7(3):422-9. PubMed ID: 10766348 [TBL] [Abstract][Full Text] [Related]
11. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin. Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224 [TBL] [Abstract][Full Text] [Related]
12. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model. Cemazar M; Miklavcic D; Mir LM; Belehradek J; Bonnay M; Fourcault D; Sersa G Eur J Cancer; 2001 Jun; 37(9):1166-72. PubMed ID: 11378348 [TBL] [Abstract][Full Text] [Related]
13. Effective treatment of perianal tumors in dogs with electrochemotherapy. Tozon N; Kodre V; Sersa G; Cemazar M Anticancer Res; 2005; 25(2A):839-45. PubMed ID: 15868917 [TBL] [Abstract][Full Text] [Related]
14. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G Br J Cancer; 1999 Mar; 79(9-10):1386-91. PubMed ID: 10188880 [TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Tozon N; Sersa G; Cemazar M Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311 [TBL] [Abstract][Full Text] [Related]
16. Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine. Deharvengt S; Rejiba S; Wack S; Aprahamian M; Hajri A Int J Oncol; 2007 Jun; 30(6):1397-406. PubMed ID: 17487360 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia. Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144 [TBL] [Abstract][Full Text] [Related]
18. Metastatic potential of melanoma cells is not affected by electrochemotherapy. Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102 [TBL] [Abstract][Full Text] [Related]
19. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas. Tevz G; Kranjc S; Cemazar M; Kamensek U; Coer A; Krzan M; Vidic S; Pavlin D; Sersa G J Gene Med; 2009 Dec; 11(12):1125-37. PubMed ID: 19777440 [TBL] [Abstract][Full Text] [Related]
20. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z Clin Cancer Res; 2000 Mar; 6(3):863-7. PubMed ID: 10741708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]